Independent Research, SPACs, SPAC Track

SPAC Track

Independent Research, SPACs

Equity Capital Markets

<ul><li>Waldencast Acquisition Corp. (WALD: warrants +45%) &amp; Obagi &amp; Milk Makeup (Valuation: $1.24B EV)</li><li>CHP Merger Corp. (CHPM: warrants +13.39%) &amp; Accelus (Valuation: $482M EV)</li><li>DFP Healthcare Acquisitions Corp. (DFHP) c<a href="https://www.globenewswire.com/news-release/2021/11/15/2334258/0/en/The-Oncology-Institute-Completes-Business-Combination-with-DFP-Healthcare-Acquisitions-Corp-to-Become-Publicly-Traded-Company.html?f=22&amp;fvtc=5&amp;fvtv=46464052" target="_blank" rel="noopener">ompleted its merger</a> with The Oncology Institute and began trading as TOI today</li></ul>

Waldencast Acquisition Corp. (WALD: warrants +45%) &amp; Obagi &amp; Milk Makeup (Valuation: $1.24B EV)CHP Merger Corp. (CHPM: warrants +13.39%) &amp; Accelus (Valuation: $482M EV)DFP Healthcare Acquisitions Corp. (DFHP) completed its merger with The Oncology Institute and began trading as TOI today

United States

Waldencast plc operates as a beauty and wellness company. The Company focuses on developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven skin care and beauty products brands. Waldencast serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Waldencast (WALD US)

The Nightcap from SPAC Track

Waldencast Acquisition Corp. (WALD: warrants +45%) & Obagi & Milk Makeup (Valuation: $1.24B EV). CHP Merger Corp. (CHPM: warrants +13.39%) &...

SPAC Track

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)